SG11202012829RA - Acetyl-coa carboxylase2 antisense oligonucleotides - Google Patents
Acetyl-coa carboxylase2 antisense oligonucleotidesInfo
- Publication number
- SG11202012829RA SG11202012829RA SG11202012829RA SG11202012829RA SG11202012829RA SG 11202012829R A SG11202012829R A SG 11202012829RA SG 11202012829R A SG11202012829R A SG 11202012829RA SG 11202012829R A SG11202012829R A SG 11202012829RA SG 11202012829R A SG11202012829R A SG 11202012829RA
- Authority
- SG
- Singapore
- Prior art keywords
- coa
- acetyl
- antisense oligonucleotides
- antisense
- oligonucleotides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
- C07K14/003—Peptide-nucleic acids (PNAs)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/53—Ligases (6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
- C12N2310/3181—Peptide nucleic acid, PNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y604/00—Ligases forming carbon-carbon bonds (6.4)
- C12Y604/01—Ligases forming carbon-carbon bonds (6.4.1)
- C12Y604/01002—Acetyl-CoA carboxylase (6.4.1.2)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020180095124A KR102304280B1 (en) | 2018-08-14 | 2018-08-14 | Acetyl-CoA Carboxylase2 Antisense Oligonucleotides |
| PCT/KR2019/009697 WO2020036353A1 (en) | 2018-08-14 | 2019-08-05 | Acetyl-coa carboxylase2 antisense oligonucleotides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202012829RA true SG11202012829RA (en) | 2021-02-25 |
Family
ID=69525636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202012829RA SG11202012829RA (en) | 2018-08-14 | 2019-08-05 | Acetyl-coa carboxylase2 antisense oligonucleotides |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11739124B2 (en) |
| EP (1) | EP3837274A4 (en) |
| JP (2) | JP2021534146A (en) |
| KR (1) | KR102304280B1 (en) |
| CN (1) | CN112566922A (en) |
| AR (1) | AR115955A1 (en) |
| AU (1) | AU2019320670B2 (en) |
| BR (1) | BR112020026541A2 (en) |
| CA (1) | CA3104658A1 (en) |
| MX (1) | MX2021000998A (en) |
| SG (1) | SG11202012829RA (en) |
| TW (1) | TWI826490B (en) |
| WO (1) | WO2020036353A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102304280B1 (en) | 2018-08-14 | 2021-09-23 | 올리패스 주식회사 | Acetyl-CoA Carboxylase2 Antisense Oligonucleotides |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6133444A (en) | 1993-12-22 | 2000-10-17 | Perseptive Biosystems, Inc. | Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions |
| US6617422B1 (en) | 1997-05-23 | 2003-09-09 | Peter Nielsen | Peptide nucleic acid monomers and oligomers |
| US20030105044A1 (en) | 2001-10-17 | 2003-06-05 | Isis Pharmaceuticals Inc. | Antisense modulation of matrix metalloproteinase 1 expression |
| US20040215006A1 (en) | 2003-04-25 | 2004-10-28 | Isis Pharmaceuticals Inc. | Modulation of tyrosinase expression |
| GB0415196D0 (en) * | 2004-07-07 | 2004-08-11 | Astrazeneca Ab | Polypeptide |
| US7211423B2 (en) * | 2004-07-23 | 2007-05-01 | Bristol-Myers Squibb Co. | Acetyl CoA carboxylase 2 sequences and methods |
| US8299041B2 (en) * | 2005-04-08 | 2012-10-30 | Isis Pharmaceuticals, Inc. | Compositions and their uses directed to acetyl-CoA carboxylases |
| BE1017127A6 (en) | 2006-03-24 | 2008-03-04 | Hyfte Luc J R Van | HINGED CONFIRMATION OF A MUSHROOM. |
| JP2010075639A (en) * | 2007-10-19 | 2010-04-08 | Shiseido Co Ltd | Method and apparatus for improving skin condition of face and neck |
| KR20090098710A (en) * | 2008-03-14 | 2009-09-17 | 주식회사 씨티아이바이오 | Peptide nucleic acid derivatives with good cell penetration and affinity for nucleic acid |
| RU2011125776A (en) | 2008-12-31 | 2013-02-10 | Реванс Терапьютикс, Инк. | COMPOSITIONS AND METHODS OF TREATING HYPERPIGMENTATION |
| WO2010123983A1 (en) | 2009-04-21 | 2010-10-28 | Yale University | Compostions and methods for targeted gene therapy |
| KR20120073536A (en) | 2010-12-27 | 2012-07-05 | 주식회사 파나진 | Peptide nucleic acid having multi-charge |
| WO2013112548A1 (en) | 2012-01-23 | 2013-08-01 | University Of South Florida | Gamma-aapeptides with potent and broad-spectrum antimicrobial activity |
| US20140314697A1 (en) | 2013-04-18 | 2014-10-23 | Corum Inc. | Method for Inhibiting Inflammation and Reducing Melanophilin Expression with Glycine Derivatives And the Composition Thereof |
| KR101809209B1 (en) | 2016-05-31 | 2017-12-15 | 주식회사 올리패스코스메슈티컬즈 | Cosmetic composition for improving the health of scalp and manufacturing method thereof |
| CA3032549A1 (en) * | 2016-08-08 | 2018-02-15 | Olipass Corporation | Androgen receptor antisense oligonucleotides |
| EP3512870B1 (en) | 2016-09-16 | 2022-08-03 | Olipass Corporation | Scn9a antisense oligonucleotides |
| WO2018069764A1 (en) | 2016-10-11 | 2018-04-19 | Olipass Corporation | Hif 1-alpha antisense oligonucleotides |
| BR112019011692A2 (en) * | 2016-12-30 | 2019-10-22 | Olipass Corp | exon bounce by peptide nucleic acid derivatives |
| BR112019013203A2 (en) * | 2017-01-06 | 2019-12-10 | Olipass Corp | snap25 antisense oligonucleotides |
| KR102592876B1 (en) | 2017-01-24 | 2023-10-23 | 올리패스 주식회사 | SCN9A antisense analgesic |
| WO2019022434A1 (en) | 2017-07-24 | 2019-01-31 | Olipass Corporation | Tyrosinase antisense oligonucleotides |
| TWI832851B (en) | 2018-05-18 | 2024-02-21 | 韓商奧利通公司 | Matrix metalloproteinase-1 antisense oligonucleotides |
| KR102304280B1 (en) | 2018-08-14 | 2021-09-23 | 올리패스 주식회사 | Acetyl-CoA Carboxylase2 Antisense Oligonucleotides |
| CN114502571A (en) | 2019-07-18 | 2022-05-13 | 奥利通公司 | Melanoidin antisense oligonucleotides |
-
2018
- 2018-08-14 KR KR1020180095124A patent/KR102304280B1/en active IP Right Grant
-
2019
- 2019-07-23 TW TW108126009A patent/TWI826490B/en active
- 2019-08-05 WO PCT/KR2019/009697 patent/WO2020036353A1/en unknown
- 2019-08-05 CN CN201980053079.5A patent/CN112566922A/en active Pending
- 2019-08-05 US US17/266,763 patent/US11739124B2/en active Active
- 2019-08-05 BR BR112020026541-1A patent/BR112020026541A2/en unknown
- 2019-08-05 JP JP2021507611A patent/JP2021534146A/en active Pending
- 2019-08-05 AU AU2019320670A patent/AU2019320670B2/en active Active
- 2019-08-05 MX MX2021000998A patent/MX2021000998A/en unknown
- 2019-08-05 CA CA3104658A patent/CA3104658A1/en active Pending
- 2019-08-05 EP EP19850610.7A patent/EP3837274A4/en active Pending
- 2019-08-05 SG SG11202012829RA patent/SG11202012829RA/en unknown
- 2019-08-14 AR ARP190102319A patent/AR115955A1/en unknown
-
2023
- 2023-12-26 JP JP2023218786A patent/JP2024038106A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TWI826490B (en) | 2023-12-21 |
| KR20200019509A (en) | 2020-02-24 |
| EP3837274A4 (en) | 2022-05-18 |
| KR102304280B1 (en) | 2021-09-23 |
| AU2019320670B2 (en) | 2024-04-11 |
| CN112566922A (en) | 2021-03-26 |
| US20210363190A1 (en) | 2021-11-25 |
| MX2021000998A (en) | 2021-06-23 |
| AU2019320670A1 (en) | 2021-02-11 |
| WO2020036353A1 (en) | 2020-02-20 |
| BR112020026541A2 (en) | 2021-04-06 |
| TW202022115A (en) | 2020-06-16 |
| US11739124B2 (en) | 2023-08-29 |
| JP2024038106A (en) | 2024-03-19 |
| AR115955A1 (en) | 2021-03-17 |
| CA3104658A1 (en) | 2020-02-20 |
| JP2021534146A (en) | 2021-12-09 |
| EP3837274A1 (en) | 2021-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2582457B (en) | Antisense oligomers specific for SCN1A | |
| IL268422A (en) | Targeted oligonucleotides | |
| GB201711809D0 (en) | Antisense oligonucleotide | |
| GB201616202D0 (en) | Antisense oligonucleotides for the treatment of eye deisease | |
| SG11201911704UA (en) | Antisense oligonucleotides for modulating the function of a t cell | |
| HK1257273A1 (en) | Combination comprising immunostimulatory oligonucleotides | |
| ZA201808291B (en) | Antisense oligonucleotides for modulating htra1 expression | |
| GB201503408D0 (en) | Oligonucleotides | |
| EP3512870A4 (en) | Scn9a antisense oligonucleotides | |
| IL258065B (en) | Antisense nucleic acids | |
| SG10201913477UA (en) | G-quadruplex-containing antisense oligonucleotides | |
| IL273394A (en) | Variant rnai | |
| IL275335A (en) | Cd19 variants | |
| GB201504124D0 (en) | Oligonucleotides | |
| ZA201905064B (en) | Scn9a antisense pain killer | |
| EP3497114A4 (en) | Androgen receptor antisense oligonucleotides | |
| EP3532617A4 (en) | Antisense oligonucleotides | |
| IL271039A (en) | Antisense oligonucleotides for modulating htra1 expression | |
| EP4041248A4 (en) | Modified oligonucleotides | |
| SG11202012829RA (en) | Acetyl-coa carboxylase2 antisense oligonucleotides | |
| EP3565825A4 (en) | Snap25 antisense oligonucleotides | |
| GB201714330D0 (en) | Oligonucleotides | |
| GB201814450D0 (en) | Antisense oligonucleotides | |
| SG10201607303YA (en) | Antisense oligonucleotides to induce exon skipping | |
| SG11201912447RA (en) | Tyrosinase antisense oligonucleotides |